- Conditions
- Intraventricular Hemorrhage
- Interventions
- tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo)
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2008
- U.S. locations
- 22
- States / cities
- Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 17 more
Source: ClinicalTrials.gov public record
Updated Dec 10, 2017 · Synced May 22, 2026, 4:14 AM EDT